careLYFE Co., Ltd. is the exclusive partner of QIAGEN in cervical cancer diagnoses and prevention in China. Using the world-leading hybrid capture technology, careLYFE helps women to detect the infection of human papillomavirus (HPV), identify the risk of developing cervical cancer and manage the progression of the disease. Over the years, we have collaborated with the Chinese Medical Associations, the Chinese Healthy Birth Science Association and the Cancer Foundation of China to promote cervical cancer education and awareness and to save thousands of lives.